Clene Inc. (CLNN): Capital Expenditures
$39.0K
Year ended 2025-12-31
$40.0K
Trailing 12 months to 2026-06-30
-80.4%
3-year compound annual growth
-36.8%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $39.0K | +160.0% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $15.0K | -95.5% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $330.0K | -93.6% | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | $5.18M | +288.8% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $1.33M | +244.2% | 2023-03-13, From 2021-01-01 |
| 2020-12-31 | $387.0K | +31.6% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $294.0K | n/a | 2021-03-29, From 2019-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Clene Inc. (CLNN) | 2025-12-31 | $39.0K | +160.0% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $28.0K | n/a |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $59.0K | +168.2% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.0K | -97.3% |
| iBio, Inc. (IBIO) | 2026-06-30 | $578.0K | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $2.0K | -60.0% |
| Medicinova Inc (MNOV) | 2025-12-31 | $2.9K | +223.9% |
| Scienture Holdings, Inc. (SCNX) | 2024-12-31 | $12.0K | n/a |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $104.0K | +845.5% |
Compare CLNN, LSTA, SER, ALLR side by side · Screen every company in Pharmaceutical Preparations ↗